We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Microscale Device Helps Keep Implantable Catheters Clear

By HospiMedica International staff writers
Posted on 14 Jun 2017
A new self-clearing technology could provide patients with neurological and other disorders reliable implantable catheters that could obviate additional surgery to replace failing devices.

Developed by researchers at Purdue University (Lafayette, IN, USA), the technology involves microscale devices with tiny magnetic elements that are located on a thin film that can be assembled into existing catheters. More...
The micromechanical devices are subsequently activated by external magnetic forces in order to remove various biomaterials that foul the catheter. By using a time-varying magnetic field, changing its magnitude, or turning it on and off, dynamic movement and mechanical vibration are created at the pore to remove the obstructive biomaterials.

The magnetic approach generates a large amount of force, and can be done without an integrated circuit or power source, making it much simpler to implement and reducing the burden of hermetic packaging for the implantation process. Mechanical evaluations, including post-release deflection and static and dynamic responses of the device have thus far been tested in chronic shunt systems used for the treatment of hydrocephalus, which requires constant diversion of excess cerebrospinal fluid (CSF) from the brain.

“When a catheter is implanted, the body’s natural reaction is to protect itself against the foreign material by forming a sheath around it. Biofouling materials including bacteria, blood, and inflammatory cells, and other tissue quickly cover the device, often blocking the catheter’s inlet pores, leading to premature device failure,” said biomedical engineer Hyowon Lee, PhD, who developed the technology. “Approximately 40% of shunt systems fail within one year of implantation, and 85% fail within 10 years, mostly due to catheter obstruction.”

Hydrocephalus can cause an enlarged head in children and cause many other life-altering physical, behavioral, and cognitive symptoms in children and adults alike. Over one million people in the United States alone suffer from hydrocephalus, and one to two newborns develop the disorder every 1,000 births. Patients can also acquire hydrocephalus later on in life due to a traumatic brain injury (TBI) or hemorrhagic stroke. The shunt systems used to reduce CSF have a high fail rate due to biofouling, and replacing the failed catheter usually requires neurosurgery, with increased risk of infection and a huge economic, physical, and emotional burden for patients and their caretakers.

Related Links:
Purdue University


Gold Member
NEW PRODUCT : SILICONE WASHING MACHINE TRAY COVER WITH VICOLAB SILICONE NET VICOLAB®
REGISTRED 682.9
Hand-held Hemoglobin Analyzer
DiaSpect Tm
Gold Member
Blood Gas Analyzer
i-Check200
Pediatric Mask
Respire SOFT
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: A UTSW clinical trial studied a treatment strategy for kidney cancer with inferior vena cava tumor thrombus (IVC-TT) that used targeted radiation on the tumor thrombus followed by surgery to remove the kidney. (Photo courtesy of UT Southwestern)

Targeted Radiotherapy Before Surgery Improves Control of Kidney Cancer Thrombus

Inferior vena cava tumor thrombus occurs when kidney cancer extends into the body’s largest vein, potentially obstructing blood flow, progressing toward the heart, and making surgery more complex.... Read more

Patient Care

view channel
Image Credit: Adobe Stock

AI Platform Personalizes Support Between Visits for Cancer Survivors

Cancer survivors often manage persistent side effects after treatment, including fatigue, anxiety, uncertainty, symptoms, stress, and questions between appointments. Clinical teams need ways to maintain... Read more

Medical Imaging

view channel
Image: Brain PET imaging could help identify Alzheimer’s patients most likely to benefit from available therapies (Image Credit: iStock)

Amyloid and Tau PET Guide Selection and Monitoring of Alzheimer’s Therapy

Alzheimer’s disease is the most common form of dementia and can be difficult to distinguish from other causes of cognitive decline. According to the World Health Organization (WHO), 57 million people were... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: Steris is expanding its healthcare consumables portfolio through an agreement to acquire Xodus Medical, a surgical products business focused on patient and operating room staff safety.

Steris to Expand Surgical Safety Portfolio With $2.1 Billion Xodus Medical Deal

Steris has signed a definitive agreement to acquire Xodus Medical, a specialty surgical products business based in Pennsylvania, for $2.1 billion at closing. The acquisition will expand Steris’s healthcare... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.